You are viewing an incomplete version of our website. Please click to reload the website as full version.

Celecoxib

Details for Product No. ABIN412148, Supplier: Log in to see
Application
Cell Culture (CC), Functional Studies (Func)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Characteristics Celecoxib is a highly selective COX-2 inhibitor and primarily inhibits prostaglandin production. Celecoxib is approximately 7.6-fold more selective for COX-2 inhibition over COX-1.This specificity allows celecoxib to reduce inflammation and pain while minimizing gastrointestinal adverse drug reactions that are common with non-selective non-steroidal anti-inflammatory drugs.
Purity 99,00 %
Molecular Weight 381.37 Da
CAS-No 169590-42-5
Restrictions For Research Use only
Format Solid
Reconstitution Solubility: Soluble in DMSO (200 mg/mL), ethanol (100 mg/mL), Poorly soluble in water.
Handling Advice Protect from light and air.
Storage -20 °C
Expiry Date 24 months
Supplier Images
 image for Celecoxib (ABIN412148) Celecoxib
Product cited in: Mao, Poschke, Wennerberg, Pico de Coaña, Egyhazi Brage, Schultz, Hansson, Masucci, Lundqvist, Kiessling: "Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms." in: Cancer research, Vol. 73, Issue 13, pp. 3877-87, 2013

Obermajer, Wong, Edwards, Chen, Scott, Khader, Kolls, Odunsi, Billiar, Kalinski: "Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling." in: The Journal of experimental medicine, Vol. 210, Issue 7, pp. 1433-445, 2013

Fujita, Kohanbash, Fellows-Mayle, Hamilton, Komohara, Decker, Ohlfest, Okada: "COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells." in: Cancer research, Vol. 71, Issue 7, pp. 2664-74, 2011

Obermajer, Muthuswamy, Lesnock, Edwards, Kalinski: "Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells." in: Blood, Vol. 118, Issue 20, pp. 5498-505, 2011

Kwon, Lee, So, Chae, Hwang, Sahoo, Nam, Rhee, Hwang, Im: "Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Issue 5, pp. 2159-64, 2010